A new startup focused on creating vaccines for cancers, influenza, and potentially even HIV launched Thursday with $54 million in funding.
Corner Therapeutics’ Series A round was led by Ziff Capital Partners, a little-known family office started by billionaire Dirk Ziff. The biotech is also being led by Spark Therapeutics co-founder Steven Altschuler, who joined Ziff Capital in 2018 as its managing director of health care ventures.
Altschuler and Ziff’s relationship goes back to the mid-2010s, when Altschuler was chief executive of the well-known research hospital Children’s Hospital of Philadelphia, or CHOP. Ziff, who is one of the heirs to the Ziff Davis publishing fortune, was sitting on CHOP’s board of trustees.
Click this link for the original source of this article.
Author: Allison DeAngelis
This content is courtesy of, and owned and copyrighted by, https://www.statnews.com and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.